Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
5(45%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
18%
Ph phase_3
1
9%
Ph not_applicable
7
64%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting4
Withdrawn1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 31 (9.1%)
N/A7 (63.6%)

Trials by Status

completed436%
withdrawn19%
recruiting436%
unknown19%
active_not_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11